期刊文献+

DT-MRI动态观察无先兆偏头痛患者治疗前后脑白质结构完整性的改变 被引量:4

Dynamic investigations of white matter abnormalities in patients with migraine without aura before and after treatment with diffusion tensor magnetic resonance imaging
原文传递
导出
摘要 目的研究无先兆偏头痛患者脑白质可能存在的微细结构异常,并探讨其在药物治疗前后的动态变化。方法选择自2010年7月113至2011年6月30日在广州医学院第二附属医院神经内科门诊连续就诊的无先兆偏头痛患者f病例组)及年龄、性别相匹配的同期健康体检者(对照组)各32例,于药物治疗前及治疗第6个月、治疗第12个月后进行磁共振弥散张量成像(DT.MRj)检查,分别于胼胝体膝部、体部及压部最厚的部位设置感兴趣区,测取部分各向异性值(FA值)和表观弥散系数值(ADC值)。结果(1)治疗前,病例组胼胝体膝部、体部及压部FA值均较对照组明显更低,差异有统计学意义(p〈0.05);治疗第6个月后,胼胝体膝部、体部FA值较治疗前明显升高,差异有统计学意义(P〈0.05);治疗第12个月后,胼胝体膝部、体部及压部FA值较治疗前及治疗第6个月均明显升高,差异有统计学意义(P〈0.05)。(2)病例组治疗前后各时间点胼胝体膝部、体部及压部ADC值与对照组比较差异均无统计学意义(p〉0.05)。(3)治疗前,病例组病程与胼胝体膝部、体部及压部FA值均呈明显负相关(r:=-0.850,P=0.000;r==-0.856,P=-0.000;r==-0.430,p=O.014);治疗第6个月后,病例组月均头痛次数与胼胝体膝部、体部及压部FA值均呈明显负相关fr==-0.824.P=-0.000;r=-0.792,P=-0.000;r=-0.425,P=-0.015);治疗第12个月后,病例组月均头痛次数与胼胝体膝部、体部FA值均呈明显负相关(r==-0.452,P=-0.009;F-0.440,P=-0.012)。结论无先兆偏头痛患者存在胼胝体神经纤维微细结构完整性的损害,经有效治疗后此种损害是可逆的。DT—MRI可动态观察无先兆偏头痛患者胼胝体神经纤维微细结构完整性的改变,值得临床推广应用。 Objective To investigate the possible microstructural abnormalities of the cerebral white matter and its dynamic changes in patients with migraine without aura before and after treatment. Methods Diffusion tensor magnetic resonance imaging (DT-MRI) was carried out before drug treatment in 32 patients with migraine without aura (case group) and 32 age- and sex-matched healthy controls (control group) who were collected in our hospital from July 1, 2010 to June 30, 2011. DT-MRI was also carried out in case group 6 and 12 months after treatment. Fractional anisotropy (FA) and apparent diffusion coefficient (ADC) were measured at genu, body, and splenium of the corpus callosum (CC), respectively. Results (1) The FA values at the genu, body, and splenium of the CC from patients with migraine without aura before treatment were significantly lower than those in the controls (P〈0.05). The FA values at the genu and body of the CC 6 months after treatment increased significantlyas compared with those before treatment (P〈0.05). The FA values at the genu, body, and splenium of the CC 12 months after treatment were significantly higher than those before treatment and 6 months after treatment (P〈0.05). (2) The ADC values at the genu, body, and splenium of the CC were not significantly different between the two groups at each time point before and after treatment (P〉0.05). (3) There were negative correlations between disease course and FA values at the genu, body, and splenium of the CC (r=-0.850, P=-0.000; r=-0.856, P=-0.000; r=-0.430, P---0.014). Negative correlations were also found between headache fi'equency and FA values at the genu, body, and splenium of the CC before treatment and 6 months after treatment (r=-0.824, P=0.000; r=-0.792, P=-0.000; r=-0.425, P=-0.015), and between headache fxequeney and FA values at the genu and body of the CC 12 months after treatment (r=-0.452, P=0.009; r=-0.440, /^-0.012). Conclusion There might be an integrity change of neurofibrotic microstructures in the CC in patients with migraine without aura, which may be reversible through effective treatment and these changes can be detected dynamically by DT-MRI, which is worth widely popularization and application.
作者 李现亮
出处 《中华神经医学杂志》 CAS CSCD 北大核心 2013年第7期714-718,共5页 Chinese Journal of Neuromedicine
基金 广东省科技计划项目,广州医学院博士、留学回国人员基金项目
关键词 偏头痛 药物治疗 脑白质 磁共振弥散张量成像 Migraine Drug treatment Cerebral white matter Diffusion tensor magneticresonance imaging
  • 相关文献

参考文献17

  • 1Kruit MC, van Buchem MA, Hofinan PA, et al. Migraine as a risk factor for subclinical brain lesions[J). JAMA, 2004, 291 (4): 427-434.
  • 2Guilbert J]. The world health report 2002 - reducing risks, promoting healthy life[J). Educ Health (Abingdon), 2003, 16(2): 230.
  • 3偏头痛诊断与防治专家共识组,李焰生.偏头痛诊断与防治专家共识[J].中华内科杂志,2006,45(8):694-696. 被引量:322
  • 4Silberstein SD. Recent developments in migraine[J). Lancet, 2008, 372(9647): 1369-137l.
  • 5王蓉飞,于生元.偏头痛发病机制的脑功能影像学研究[J].中华神经医学杂志,2006,5(3):311-313. 被引量:13
  • 6Li XL, Fang YN, Gao QC, et al. A diffusion tensor magnetic resonance imaging study of corpus callosum from adult patients with migraine complicated with depressive/anxious disorder[J). Headache, 2011, 51(2): 237-245.
  • 7Headache Classification Subcommittee ofthe International Headache Society. The International Classification of Headache Disorders: 2nd edition[J). Cephalagia, 2004, 24 Suppll: 9-160.
  • 8花蒨蒨,张雪林.磁共振扩散张量成像在中枢神经系统的应用研究进展[J].中华神经医学杂志,2007,6(12):1286-1289. 被引量:5
  • 9DaSilva AF, Granziera C, Tuch DS, et al. Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine[J). Neuroreport, 2007, 18(4): 301-305.
  • 10Rocca MA, Colombo B, Pagani E, et al. Evidence for cortical functional changes in patients with migraine and white matter abnormalities on conventional and diffusion tensor magnetic resonance imaging[J). Stroke, 2003, 34(3): 665-670.

二级参考文献56

  • 1Bramanti P, Grugno R, Vitetta A, et al.Migraine with and without aura:electrophysiological and functional neuroimaging evidence[J]. Funct Neurol, 2005, 20(1): 29-32.
  • 2Cao Y, Welch KM, Aurora S, et al. Functional MRI-BOLD of visually triggered headache in patients with migraine[J]. Arch Neurol, 1999,56(5): 548-554.
  • 3Cao Y, Aurora SK, Nagesh V, et al. Functional MRI-BOLD of brainstem structures during visually triggered migraine [J].Neurology, 2002, 59(1): 72-78.
  • 4Sarchielli P, Tarducci R, Presciutti O, et al. Functional ^1H-MRS findings in migraine patients with and without aura assessed interictally[J]. Neuroimage, 2005, 24(4): 1025-1031.
  • 5Watanabe H, Kuwabara T, Ohkubo M, et al. Elevation of cerebral lactate detected by localized 1H-magnetic resonance spectroscopy in migraine during the interictal period[J]. Neurology, 1996, 47(4):1093-1095.
  • 6Montagna P. Magnetic resonance spectroscopy in migraine [J].Cephalalgia, 1995, 15(4): 323-327.
  • 7Boska MD, Welch KM, Barker PB, et al. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes[J]. Neurology, 2002, 58(8): 1227-1233.
  • 8Sandor PS, Dydak U, Schoenen J, et al. MR-spectroscopic imaging during visual stimulation in subgroups of migraine with aura[J].Cephalalgia, 2005, 25(7): 507-518.
  • 9Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomographic study in spontaneous migraine[J]. Arch Neurol, 2005, 62(8): 1270-1275.
  • 10Matharu MS, Goadsby PJ. Functional brain imaging in hemicrania continua: implications for nosology and pathophysiology [J]. Curr Pain Headache Rcp, 2005, 9(4): 281-288.

共引文献334

同被引文献46

  • 1郭起浩,洪震,吕传真,于欢,丁玎.Mattis痴呆评定量表(中文版)的效度分析[J].中国临床心理学杂志,2004,12(3):237-238. 被引量:21
  • 2Kurth T, Mohamed S, Maillard P, Zhu YC, Chabriat H, Mazoyer B, Bousser MG, Dufouil C, Tzourio C. Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ, 2011, 342: C7357.
  • 3Yu S, Liu R, Zhao G, Yang X, Qiao X, Feng J, Fang Y, Cao X, He M, Steiner T. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache, 2012, 52: 582-591.
  • 4Kruit MC, van Buchem MA, Launer LJ, Terwindt GM, Ferrari MD. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population- based MRI CAMERA study. Cephalalgia, 2010, 30:129-136.
  • 5Garg P, Servoss SJ, Wu JC, Bajwa ZH, Selim MH, Dineen A, Kuntz RE, Cook EF, Mauri L. Lack of association between migraine headache and patent foramen ovale: results of a case- control study. Circulation, 2010, 121:1406-1412.
  • 6Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology, 1999, 52:1622-1625.
  • 7Yang Y, Gun ZN, Wu J, Jin H, Wang X, Xu J, Feng J, Xing Y. Prevalence and extent of right-to-left shunt in migraine: a survey of 217 Chinese patients. Eur J Neurol, 2012, 19:1367-1372.
  • 8Gil-Gouveia R, Oliveira AG, Martins IP. A subjective cognitive impairment scale for migraine attacks. The MIG- SCOG: development and validation. Cephalalgia, 2011, 31:984-991.
  • 9Schmitz N, Admiraal-Behloul F, Arkink EB, Kruit MC, Schoonman GG, Ferrari MD, van Buchem MA. Attack frequency and disease duration as indicators for brain damage in migraine. Headache, 2008, 48:1044-1055.
  • 10Swartz RH, Kern RZ. Migraine is associated with magnetic resonance imaging white matter abnormalities: a meta-analysis. Arch Nem'ol, 2004, 61:1366-1368.

引证文献4

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部